Literature DB >> 18046229

Foveal thickness and macular volume in patients with oculocutaneous albinism.

Natalio J Izquierdo1, Andrés Emanuelli, Juan C Izquierdo, Maribel García, Carmen Cadilla, María H Berrocal.   

Abstract

PURPOSE: To measure foveal thickness and macular volume in patients with oculocutaneous albinism (OCA) using optical coherence tomography (OCT) technology and to evaluate the possible association between albinism type and OCT retinal findings.
METHODOLOGY: The authors measured retinal structures such as foveal thickness and macular volume of patients and obligate carriers of the various types of OCA using OCT technology.
RESULTS: Participants with OCA (all types included) have thicker foveas (P = 0.0009) and less macular volume (P = 0.0022) than the general population. Carriers of mutations leading to OCA (all types included) have normal foveal thicknesses and higher macular volumes (P = 0.0009) than the general population. Participants with Hermansky-Pudlak syndrome (HPS)-Type 1 have thicker foveas but less macular volume (P = 0.0468) than the general population.
CONCLUSIONS: Results of this study suggest that patients with OCA (all types included) and patients with HPS-1 have thicker foveas than the general population. This may be due to the absence of foveal pit as part of foveal hypoplasia associated with OCA. Conversely, participants have lower macular volumes than the general population. This finding is compatible with loss of retinal nuclear layers in patients with OCA.

Entities:  

Mesh:

Year:  2007        PMID: 18046229     DOI: 10.1097/IAE.0b013e3180592b48

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3).

Authors:  Javier Jardón; Natalio J Izquierdo; Jessica Y Renta; Omar García-Rodríguez; Carmen L Cadilla
Journal:  Ophthalmic Genet       Date:  2014-04-28       Impact factor: 1.803

2.  Macular optical coherence tomography findings and GPR143 mutations in patients with ocular albinism.

Authors:  H E Sepúlveda-Vázquez; C Villanueva-Mendoza; J C Zenteno; V Villegas-Ruiz; E Pelcastre-Luna; G García-Aguirre
Journal:  Int Ophthalmol       Date:  2014-02-14       Impact factor: 2.031

3.  Ultra-widefield Fundus Image in Oculocutaneous Albinism.

Authors:  Tanyatuth Padungkiatsagul; Lakshmi Leishangthem; Heather E Moss
Journal:  JAMA Ophthalmol       Date:  2020-09-10       Impact factor: 7.389

4.  Albinism: Images in ophthalmology.

Authors:  O K Sreelatha; E Al-Harthy; P Vanrijen-Cooymans; S Al-Zuhaibi; A Ganesh
Journal:  Oman J Ophthalmol       Date:  2009-01

5.  The role of optical coherence tomography in an atypical case of oculocutaneous albinism: a case report.

Authors:  Settimio Rossi; Francesco Testa; Annagiusi Gargiulo; Valentina Di Iorio; Raffaella Brunetti Pierri; Francesco Maria D'Alterio; Michele Della Corte; Enrico Surace; Francesca Simonelli
Journal:  Case Rep Ophthalmol       Date:  2012-03-27

6.  Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Authors:  Hammad A Qazi
Journal:  J Res Med Sci       Date:  2012-12       Impact factor: 1.852

7.  Characterization of Retinal Thickness in Individuals with Albinism: Baseline Data for a Black South African Population.

Authors:  Ethan Pillay; Thiroshnee Naidoo; Khadija Asmal; Lilitha Maliwa; Sinenhlanhla Mchunua; Diane Beverly van Staden; Nishanee Rampersad
Journal:  Clin Optom (Auckl)       Date:  2021-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.